Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Association between early central venous pressure monitoring and 30-day mortality in critically ill patients with comorbid heart failure and sepsis: A retrospective cohort study.

Created on 07 Nov 2026

Authors

Chengrong Zheng, Lili Wang, Sang Zhou, Xiang Liao, Zheng Zhang, Zhitao Jin

Published in

Medicine. Volume 105. Issue 45. Pages e51441. Nov 06, 2026.

Abstract

Central venous pressure (CVP) is widely used in the intensive care unit (ICU), but the optimal timing to initiate CVP monitoring remains unclear for patients with comorbid heart failure and sepsis. We explored the association between time to initial CVP measurement and 30-day mortality in this high-risk population. This retrospective cohort study included 9246 critically ill patients with comorbid heart failure and sepsis from the MIMIC-IV database. Restricted cubic spline (RCS) analysis examined the relationship between time to initial CVP measurement and 30-day mortality. Inverse probability of treatment weighting followed by weighted logistic regression was used to assess the association between early CVP monitoring (≤6 hours after ICU admission) and 30-day mortality. A nonlinear J-shaped association emerged, with the lowest risk at 2.89 hours post-admission. Early CVP monitoring was associated with lower 30-day mortality (OR = 0.816, 95% CI: 0.688-0.967, P = .019). A landmark sensitivity analysis comparing no monitoring, early (≤6 hours), intermediate (6-86 hours), and late (>86 hours) monitoring showed a time-dependent relationship: intermediate (OR = 1.396, 95% CI: 1.194-1.632, P < .001) and late monitoring (OR = 3.141, 95% CI: 2.263-4.359, P < .001) were associated with progressively higher mortality. In critically ill patients with comorbid heart failure and sepsis, early CVP monitoring within 6 hours of ICU admission was associated with lower 30-day mortality, while delayed monitoring carried an elevated risk. Early integration of CVP within a multimodal hemodynamic assessment framework may be a prudent approach in this high-risk population.

PMID:
42994883
Bibliographic data and abstract were imported from PubMed on 07 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement